Modulation of Autophagy in Patients With Advanced/Recurrent Non-small Cell Lung Cancer - Phase II

NCT01649947 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Non-small Cell Lung Cancer
Advanced Non-small Cell Lung Cancer
Recurrent Non-small Cell Lung Cancer

Interventions

DRUG: Paclitaxel
DRUG: Carboplatin
DRUG: Hydroxychloroquine
DRUG: Bevacizumab

Sponsor

Rutgers, The State University of New Jersey

Collaborators

[object Object]
[object Object]